Cargando…
Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
Still, there is need for significant improvements in reliable and accurate diagnosis for Alzheimer's disease (AD) at early stages. It is widely accepted that changes in the concentration and conformation of amyloid-β (Aβ) appear several years before the onset of first symptoms of cognitive impa...
Autores principales: | Kühbach, Katja, Hülsemann, Maren, Herrmann, Yvonne, Kravchenko, Kateryna, Kulawik, Andreas, Linnartz, Christina, Peters, Luriano, Wang, Kun, Willbold, Johannes, Willbold, Dieter, Bannach, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731524/ https://www.ncbi.nlm.nih.gov/pubmed/26858588 http://dx.doi.org/10.3389/fnins.2016.00008 |
Ejemplares similares
-
Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
por: Kass, Bettina, et al.
Publicado: (2022) -
Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting
por: Blömeke, Lara, et al.
Publicado: (2022) -
Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer’s Disease
por: Pils, Marlene, et al.
Publicado: (2023) -
Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering
por: Zhang-Haagen, Bo, et al.
Publicado: (2016) -
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
por: Schemmert, Sarah, et al.
Publicado: (2018)